AMIRA Meditech

AMIRA Meditech is a Bulgarian start-up dedicated to tackling the pressing issue of antimicrobial resistance (AMR) through the development of a software solution aimed at guiding doctors in antibiotic prescription. Their slogan, "Building a software solution to guide doctors during antibiotic prescription and help fight AMR," succinctly captures the essence of their mission. The company's description underscores their commitment to providing comprehensive support to medical specialists in optimizing antibiotic prescription for each patient, with a focus on mitigating the emerging threat of AMR. Despite the absence of specific details regarding the company's founding date, industries, or headquarters, AMIRA Meditech's innovative approach to addressing AMR presents a compelling opportunity for venture capital investment. With a dedicated focus on a global health challenge, the potential impact of their solution is significant. While information about their last investment and investors is not currently available, the company's unique value proposition and the growing urgency surrounding AMR position them as a promising investment prospect in the healthcare and technology sectors.